https://apnews.com/press-release/business-wire/science-health-a1c463ef4d874749a27490c0b4fdec28
Global Stem Cell Manufacturing Market Research Report 2022: $6.77 Billion in Growth by 2026 - ResearchAndMarkets.com
The stem cell manufacturing market is poised to grow by $ 6.77 billion during 2022-2026, progressing at a CAGR of 9.69%. This market report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The market is driven by the rising prevalence of several chronic disorders and rising focus on regenerative medicines as well as the increased federal investment in stem cell therapy.
https://www.researchandmarkets.com/reports/5546069/global-stem-cell-manufacturing-market-2022-2026
The publisher recognizes the following companies as the key players in the global stem cell manufacturing market: Becton Dickinson and Co., Bio Techne Corp., Corning Inc., Danaher Corp., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., Sartorius AG, STEMCELL Technologies Inc., and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from the research team said: The latest trend gaining momentum in the market is increased federal investment in stem cell therapy.
According to the report, one of the major drivers for this market is the rising prevalence of several chronic disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.